Tokyo, Sept. 24 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063027) titled 'Video-based AI motion analysis of physical function in patients with cardiovascular disease' on Sept. 23.

Study Type: Observational

Primary Sponsor: Institute - Kumamoto University

Condition: Condition - Cardiovascular disease requiring hospitalization, including heart failure, ischemic heart disease, valvular heart disease, arrhythmia, pulmonary hypertension, and peripheral artery disease Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To evaluate the feasibility of video-based artificial intelligence motion analysis during Short Physical Performance Battery (SPPB) testing performed as part of routine inpatient care in patients hospitalized for cardiovascular disease, and to explore associations between video-derived motion features and conventional physical performance measures, frailty, activities of daily living, musculoskeletal conditions, and post-discharge outcomes, in order to establish human movement as a quantitative digital vital sign. Basic objectives2 - Others

Eligibility: Age-lower limit - 20 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - 1. Aged 20 years or older 2. Hospitalized at Kumamoto University Hospital for cardiovascular disease (heart failure, ischemic heart disease, valvular heart disease, arrhythmia, pulmonary hypertension, peripheral artery disease, etc.) or undergoing inpatient cardiac rehabilitation 3. Scheduled to undergo the Short Physical Performance Battery (SPPB) or part of it during hospitalization or before discharge 4. Able to perform at least one video-recordable physical performance task 5. Able to provide written informed consent Key exclusion criteria - 1. Aged under 20 years 2. Active malignancy, severe infection, or severe trauma 3. Physical performance testing considered unsafe because of hemodynamic instability, severe respiratory compromise, acute neurological deterioration, or other unstable medical conditions 4. Unable to perform any of the 3 SPPB components because of severe physical disability 5. Severe cognitive impairment or communication difficulty precluding understanding of the study procedures 6. Participation judged inappropriate by the attending physician or the investigator Target Size - 150

Recruitment Status: Recruitment status - Enrolling by invitation Date of protocol fixation - 2025 Year 09 Month 12 Day Date of IRB - 2025 Year 09 Month 12 Day Anticipated trial start date - 2026 Year 01 Month 01 Day Last follow-up date - 2035 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072149

Disclaimer: Curated by HT Syndication.